Late-onset allergy-like reactions to X-ray contrast media

Current Opinion in Allergy and Clinical Immunology

Volumn 2, Issue 4, 2002, Pages 333-339

  Christiansen, Cath ^a,b  

^a Research and Development   (Norway)

^b Amersham Health   (Norway)

Author keywords

Allergy like reactions; Contrast media; Late onset reactions; Prophylaxis; T cells

Indexed keywords

ANTIHISTAMINIC AGENT; CONTRAST MEDIUM; DIATRIZOATE; IOBITRIDOL; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPENTOL; IOPROMIDE; IOTROLAN; IOVERSOL; IOXILAN; MEGLUMINE DIATRIZOATE; MEGLUMINE IOTALAMATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE;

ALLERGIC REACTION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DRUG ERUPTION; ERYTHEMA; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RASH; REVIEW; RISK FACTOR; SKIN MANIFESTATION; T LYMPHOCYTE; URTICARIA; X RAY; CHEMICALLY INDUCED DISORDER; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; TIME;

CONTRAST MEDIA; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; INJECTIONS, INTRAVENOUS; TIME FACTORS;

EID: 0036674944     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200208000-00007     Document Type: Review

References (47)

1. Stacul F. Current iodinated contrast media. Eur Radiol 2001; 11:690-697. This review provides a good overview of clinical experience with the different types of contrast media that are currently available.
2. Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 2000; 10:1965-1975.
3. Hosoya T, Yamaguchi K, Akutsu T, et al. Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 2000; 18:39-45.
4. Rydberg J, Charles J, Aspelin P. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium. Acta Radiol 1998; 39:219-222.
5. Akiyama M, Nakada T, Sueki H, et al. Drug eruption caused by nonionic iodinated X-ray contrast media. Acad Radiol 1998; 5(suppl 1):S159-S161.
6. Yamauchi R, Morita A, Tsuji T. Fixed drug eruption caused by iopamidol, a contrast medium. J Dermatol 1997; 24:243-245.
7. Watanabe H, Sueki H, Nakada T, et al. Multiple fixed drug eruption caused by iomeprol (Iomeron®), a nonionic contrast medium. Dermatology 1999; 198:291-294.
8. Borofsky HB, Barnard CM, Lang EV. Fixed bullous drug eruption due to iohexol. Adv X-Ray Contrast 1993; 1:58-60.
9. Good AE, Novak E, Sonda P, Arbor A. Fixed eruption and fever after urography. Southern Med J 1980; 73:948-949.
10. Benson PM, Giblin WJ, Douglas DM. Transient, nonpigmenting fixed drug eruption caused by radiopaque contrast media. J Am Acad Dermatol 1990; 23:379-381.
11. Reynolds NJ, Wallington TB, Burton JL. Hydrallazine predisposes to acute cutaneous vasculitis following urography with iopamidol. Br J Dermatol 1993; 129:82-85.
12. Goodfellow T, Holdstock GE, Brunton FJ, Bamforth J. Fatal acute vasculitis after high-dose urography with iohexol. Br J Radiol 1986; 59:620-621.
13. Savill JS, Barrie R, Ghosh S, et al. Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad Med J 1988; 64:392-394.
14. Schmidt BJ, Foley WD, Bohorfoush AG. Toxic epidermal necrolysis related to oral administration of diluted diatrizoate meglumine and diatrizoate sodium. Am J Roentgenol 1998; 171:1215-1216,
15. Rosado A, Canto G, Veleiro B, Rodríguez J. Toxic epidermal necrolysis after repeated injections of iohexol. Am J Roentgenol 2001; 176:262-263.
16. Miranda-Romero A, Sánchez-Sambucety P, Esquivias Gómez JI, et al. Vegetating iododerma with fatal outcome. Dermatology 1999; 198:295-297.
17. Vaillant L, Pengloan J, Blanchier D, et al. Iododerma and acute respiratory distress with leucocytoclastic vasculitis following the intravenous injection of contrast medium. Clin Exp Dermatol 1990; 15:232-233.
18. Newman B. Delayed adverse reaction to nonionic contrast agents. Pediatr Radiol 2001; 31:597-599. An unusual, life-threatening late-onset reaction following contrast-media-enhanced computed tomography is described.
19. Savader SJ, Brodkin J, Osterman FA. Delayed life-threatening reaction to non-ionic contrast media. J Interv Radiol 1995; 10:115-116.
20. Burton PR, Jarmolowski E, Raineri F, et al. A severe, late reaction to radiological contrast media mimicking a sepsis syndrome. Australas Radiol 1999; 43:360-362.
21. Yamaguchi K, Takanashi I, Kanauchi T, et al. A retrospective survey of delayed adverse reactions to ionic and nonionic contrast media. Nippon Igaku Hoshasen Gakkai Zasshi 1992; 52:1565-1570.
22. Niendorf HP. Delayed allergy-like reactions to X-ray contrast media. Problem statement exemplified with iotrolan (Isovist) 280. Eur Radiol 1996; 6(suppl 3):S8-S10.
23. Pedersen SH, Svaland MG, Reiss A-L, Andrew E. Late allergy-like reactions following vascular administration of radiography contrast media. Acta Radiol 1998; 39:344-348.
24. Sutton AGC, Finn P, Grech ED, et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 2001; 141:677-683. The study presented in this article confirms that late-onset allergy-like reactions after exposure to contrast media are mainly nonserious skin reactions, with iodixanol shown to give more such reactions than the two other contrast media investigated.
25. Yasuda R, Munechika H. Delayed adverse reactions to nonionic monomeric contrast-enhanced media. Invest Radiol 1998; 33:1-5.
26. Courvoisier S, Bircher AJ. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium. Allergy 1998; 53:1221-1224.
27. Takeuchi M, Masutani M, Matsunaga K. A case of drug eruption caused by Omnipaque (iohexol). Environ Dermatol 1995; 2(suppl 1):65.
28. Asano S, Ikeda M, Ichikawa E, et al. Drug eruption due to iohexol [in Japanese]. Rinsho Hoshasen 1990; 35:533-536.
29. Torinuki W, Maehara I. Drug eruption due to nonionic x-ray contrast medium, iotrolan. Cases with immediate or delayed onset of skin rash. Tohoku J Exp Med 1996; 179:61-63.
30. Brockow K, Becker EW, Worret W-I, Ring J. Late skin test reactions to radiocontrast medium. J Allergy Clin Immunol 1999; 104:1107-1108.
31. Yoshikawa H. Late adverse reactions to nonionic contrast media. Radiology 1992; 183:737-740.
32. Choyke PL, Miller DL, Lotze MT, et al. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992; 183:111-114.
33. Hari Y, Frutig-Schnyder K, Hurni M, et al. T-cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31:1398-1408. This very interesting article demonstrates the involvement of drug-specific T cells in different types of drug-induced skin eruptions.
34. Orasch CE, Helbling A, Zanni MP, et al. T-cell reaction to local anaesthetics: relationship to angioedema and urticaria after subcutaneous application-patch testing and LTT in patients with adverse reaction to local anaesthetics. Clin Exp Allergy 1999; 29:1549-1554.
35. Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107:1433-1441. This study confirms the involvement of interleukin-8-secreting drug-specific T cells in the drug-induced neutrophilic inflammation of exanthematous pustulosis.
36. Sedano E, Vega JM, Rebollo S, et al. Delayed exanthema to nonionic contrast medium. Allergy 2001; 56:1015-1016. Two cases of late-onset exanthema occurring 24 hours after the patients' first exposure to a contrast medium are described. Both patients were patch test positive to the culprit contrast medium.
37. Schnyder B, Frutig K, Mauri-Heliweg D, et al. T-cell mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction. Clin Exp Allergy 1998; 28:1412-1417.
38. Kanzaki T, Sakagami H, Late phase allergic reaction to a CT contrast medium (iotrolan). J Dermatol 1991; 18:528-531.
39. Gall H, Pillekamp H, Peter R-U. Late-type allergy to the X-ray contrast medium Solutrast® (iopamidol). Contact Dermatitis 1999; 40:248-250.
40. Schick E, Weber L, Gall H. Delayed hypersensitivity reaction to the non-ionic contrast medium iopromid. Contact Dermatitis 1996; 35:312.
41. Kanny G, Marie B, Hoen B, et al. Delayed adverse reaction to sodium ioxaglic acid-meglumine. Eur J Dermatol 2001; 11:134-137. This paper describes the diagnostic work-up of a patient with maculopapular rash combined with fever, eosinophilia, and hepatic and muscular involvement after exposure to ioxaglate.
42. Kanny G, Morisset M, Beaudouin E, et al. Delayed hypersensitivity reactions to iodinated contrast media [abstract 32]. J Allergy Clin Immunol 2001; 107:S10.
43. Erdmann S, Roos T, Merk HF. Delayed hypersensitivity reaction to the nonionic contrast medium ioversol [in German]. Aachener Dermatologenabend 2000; 75:169-171.
44. Angeles Gozalo-Garijo M, de Argila D, Pimentel JJ, et al. Skin reaction to contrast medium. Allergy 1997; 52:875-876.
45. Moneret-Vautrin DA, Kanny G, Morisset M, et al. Anaphylactoid reactions and late skin reactions to iodinated contrast media: the current state of the question development of ideas [in French]. Rev Med Interne 2001; 22:969-977. In this review the authors list measures to be taken to prevent serious reactions to contrast media.
46. Morcos SK, Thomsen HS, Webb JAW. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 2001; 11:1720-1728. This paper summarizes current practice among members of the European Society of Urogenital Radiology for reducing the risk of generalized contrast media reactions.
47. Pichler WJ, Yawalkar N. Allergic reactions to drugs: involvement of T cells. Thorax 2000; 55(suppl 2):S61-S65.